Diversity and Inclusion in Pancreatic Cancer Clinical Trials

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 161; no. 6; pp. 1741 - 1746.e3
Main Authors Herremans, Kelly M., Riner, Andrea N., Winn, Robert A., Trevino, Jose G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2021
Subjects
Clinical Trials as Topic
Ethnic and Racial Minorities
Female
Health Status Disparities
Healthcare Disparities - ethnology
Humans
Incidence
Male
Minority Groups
Minority Health - ethnology
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - ethnology
Pancreatic Neoplasms - therapy
Patient Selection
Race Factors
Research Subjects
Sex Factors
EF
NCI
FDA
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Dr. Herremans, Dr. Riner, Dr. Winn and Dr. Trevino each made substantial contributions to the design, analysis, drafting and revision of the manuscript.
Contributors: On behalf of the pancreatic cancer clinical trials diversity study group, Daniel W. Neal, MS1; Katherine Y. Tossas, PhD, MS2; Syed Ammer Shah, MD, MSc3; Brian J. Kaplan, MD3; Shreya Raman, BS3; Catalina Mosquera, MD3; Gilbert R. Upchurch, Jr, MD1; Steven J. Hughes, MD1; Thomas J. George, MD4
ISSN:0016-5085
1528-0012
1528-0012
DOI:10.1053/j.gastro.2021.06.079